iBio Inc (IBIO): 55% short interest as of Friday’s tradin...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	1
Posts	35
Boards Moderated	0
Alias Born	11/26/2012

beavertrader

Re: None

Monday, 03/02/2020 12:54:58 AM

Monday, March 02, 2020 12:54:58 AM

55% short interest as of Friday’s trading volume. Will be a nice short squeeze, if momentum continues.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent IBIO News

Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 09:24:33 PM
iBio Expands Executive Leadership Team with Appointment of Kristi Sarno as Senior Vice President of Business Development • GlobeNewswire Inc. • 08/12/2024 08:30:00 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/06/2024 09:02:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 01:03:41 PM
Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/25/2024 09:05:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 08:02:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:10:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 08:08:04 PM
iBio Closes Sale of Manufacturing Facility in Texas • GlobeNewswire Inc. • 06/03/2024 11:00:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 10:55:47 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:32:43 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:30:55 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:14:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:08:29 PM
iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/13/2024 08:05:00 PM
iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases • GlobeNewswire Inc. • 03/27/2024 11:00:00 AM
iBio Announces $15.0 Million Private Placement • GlobeNewswire Inc. • 03/26/2024 11:35:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 12:59:30 PM
iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka • GlobeNewswire Inc. • 02/26/2024 12:45:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:55:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:36:09 PM
iBio Announces Participation in 23rd Annual PepTalk Conference • GlobeNewswire Inc. • 01/16/2024 01:15:00 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/10/2024 06:24:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 09:30:59 PM

More IBIO News

InvestorsHub NewsWire

Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM

Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM

ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM

North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM

PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM

Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover